Report: Combination of health goods risky

Jul 22, 2007

A study in Canada has found the health industry has not adequately recognized the danger of pairing natural health products with prescription medication.

Research conducted at the University of Alberta featuring 132 pharmacists found that while nearly half had patients with possible side effects from the health combination, just 1.5 percent reported them to Canadian health officials, a release said Friday.

"The data show that adverse events are not being reported or are being under-reported at a dramatic rate," co-author of the study, Dr. Sunita Vohra, said. "Natural health products should be treated with due respect."

Vohra did point out that such harmful occurrences only represented a small portion of the overall use of natural health products in Canada.

The natural health products focused on in the study included vitamins, garlic, St. John's wort, Echinacea and minerals probiotics.

The group suggested using active surveillance and offering customers additional information to avoid such potentially harmful interactions.

Copyright 2007 by United Press International

Explore further: Supercomputers link proteins to drug side effects

add to favorites email to friend print save as pdf

Related Stories

Microsoft CEO launches diversity training effort

54 minutes ago

(AP)—Microsoft CEO Satya Nadella has again apologized to employees and announced in a company-wide memo that all workers will receive expanded training on how to foster an inclusive culture as he works to repair damage ...

'Red effect' sparks interest in female monkeys

2 hours ago

Recent studies showed that the color red tends increase our attraction toward others, feelings of jealousy, and even reaction times. Now, new research shows that female monkeys also respond to the color red, ...

Recommended for you

Supercomputers link proteins to drug side effects

10 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

18 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0